Lindsay Bisby
Psychiatric/Mental Health · San Marcos, TXNPI 1538878459
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.3% of the total across 156 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by AbbVie at 26.5% of the total. Reporting peaked in 2023 at $1,660 and has fallen 62.5% since, to $622 in 2025.
Across 156 payments — averaging $18.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$767
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$505
- Otsuka America Pharmaceutical, Inc.$353
- Lundbeck LLC$234
- Alkermes, Inc.$170
- Johnson & Johnson$144
- plus $719 from 17 others
What the payments were for
- Food & beverage$2,84198%
- Education$492%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 48 | $767 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 22 | $505 |
| Otsuka America Pharmaceutical, Inc. | 20 | $353 |
| Lundbeck LLC | 15 | $234 |
| Alkermes, Inc. | 10 | $170 |
| Johnson & Johnson | 3 | $144 |
| Axsome Therapeutics, Inc. | 6 | $113 |
| Noven Therapeutics, LLC | 4 | $79 |
| Vanda Pharmaceuticals Inc. | 4 | $70 |
| Tris Pharma Inc | 4 | $69 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $56 |
| Corium, LLC | 3 | $47 |
| Teva Pharmaceuticals USA, Inc. | 2 | $46 |
| Supernus Pharmaceuticals, Inc. | 2 | $45 |
| Collegium Pharmaceutical, Inc. | 2 | $43 |
| E.r. Squibb & Sons, L.L.C. | 1 | $32 |
| OWP Pharmaceuticals, Inc. | 1 | $22 |
| Biogen | 1 | $19 |
| Indivior Inc. | 1 | $18 |
| Ironshore Pharmaceuticals Inc. | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Vertical Pharmaceuticals, LLC | 1 | $15 |
| Neurocrine Biosciences, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$111
How this compares
$2,890 in reported general payments places this provider in the 80th percentile of 2,724 psychiatric/mental health providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 14 | $458 |
| Quetiapine Fumarate | 21 | $353 |
| Duloxetine Hcl | 16 | $299 |
| Escitalopram Oxalate | 13 | $95 |
| Alprazolam | 24 | $82 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 12 | $64 |
| Lamotrigine | 17 | $52 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in San Marcos
- Tracy HicksLongview$684K
- Natalie TellezHouston$602K
- Karah BrashierRichardson$567K
- Grant DavisRichardson$360K
- Victor IlogEl Paso$167K
- Lisa ShamblinGrapevine$163K
- Monique GonzalezSan Antonio$126K
- Marguerite AddisonWaco$118K
- Komi Kokou-AbiRound Rock$88K
- Jaime Nelson DensonAustin$88K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.